Researchers at St. Michael’s Hospital have found a biomarker from fluid in the eye that predicts which patients will respond best to current treatments for diabetic macular edema, one of the most common complications of diabetes.

This post comes from the RSS feed of EurekaAlert, you can find more here!

Written by admin